Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Painful Cutaneous Leiomyomas
NCT00971620Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2008
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Cutaneous Leiomyoma (CLM), sponsored by National Cancer Institute. Started Nov 2008; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Cutaneous Leiomyoma (CLM)
Beyond the preview
Go deeper on NCT00971620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00971620.